-
Ebola vaccine for West Africa still in Canada, 6 weeks after it was promised
The experimental Ebola vaccine that Canada promised to ship to West Africa to help fight the epidemic six weeks ago has yet to be shipped to West Africa a, says Dr. Gregory Taylor, the country's new chief public health officer.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Project to develop room-temperature storage for fragile biologics
A project at McMaster University is receiving $112,000 in seed funding from Grand Challenges Canada ... (to) adapt an existing technology to make vaccines for deadly illnesses more affordable and available for use in resource-poor areas.
- Categories
- Education, Health Care
-
Ebola drug trials to be fast-tracked in West Africa
Experimental Ebola drugs including compounds from Mapp Biopharmaceutical, Sarepta and Tekmira will be tested in affected West African states for the first time in a bid to fast-track trials, the Wellcome Trust said on Tuesday.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Obama Goes to UN With Islamic State, Ebola on Agenda
President Barack Obama heads to the United Nations General Assembly this week with two missions: to rally international support for a coalition against Islamic State militants in Iraq and Syria and to back his plan to fight the Ebola virus in West Africa.
- Categories
- Education, Health Care
-
Wireless sensor warns if vaccines get too hot
A wireless sensor that sends text message alerts to healthcare workers could help better protect temperature-sensitive vaccines and provide crucial data on storage, transport and distribution infrastructures in developing nations, according to its inventors.
- Categories
- Health Care
-
How Price Discrimination is Good for Global Health (Part 2): Patricia Danzon describes how the concept, despite its theoretical upside, ‘is not working very well’ in practice
?In Part 1 of her interview with NBHC, professor Patricia Danzon of The Wharton School, University of Pennsylvania laid out some of the advantages of differential pricing in pharmaceuticals. In Part 2, she describes how the concept works in practice, including the key role of politics in its implementation.
- Categories
- Education, Health Care
-
Glaxo’s Ebola Vaccine and the Rise of Tropical-Disease R&D
Financial arguments may finally be leading Big Pharma to increase its minuscule investment in research and development of new drugs for tropical diseases.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
FDA rushes J&J, NewLink Genetics Ebola vaccines to clinical trials
Another Big Pharma player is joining the hustle toward an Ebola vaccine as the death toll surpasses 1,900 victims, eclipsing the total number of people who died from the disease in all previous outbreaks combined.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.